» Articles » PMID: 29146892

Intermedin Ameliorates Atherosclerosis by Increasing Cholesterol Efflux Through the CAMP-PKA Pathway in Macrophage RAW264.7 Cell Line

Overview
Journal Med Sci Monit
Date 2017 Nov 18
PMID 29146892
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND The aim of this study was to explore the role of intermedin and its mechanism in cholesterol efflux of macrophage THP-1 and RAW264.7 cell lines in atherosclerosis (AS). MATERIAL AND METHODS ApoE-/- mice were fed with a high-fat diet, and the concentrations of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were measured. The lipidoses of the aortic sinus were analyzed by hematoxylin and eosin staining, and the cAMP level was detected by enzyme-linked immunosorbent assay (ELISA). The expressions of ATP-binding cassette transporter (ABCA1) were tested by real-time PCR and Western blot analysis. RESULTS IMD decreased serum TC and LDL-C, and increased serum HDL-C level in apoE-/- mice and attenuated AS plaque areas. In vitro, IMD increased intracellular cAMP concentration in a dose-dependent manner in THP-1 and RAW264.7 cell lines, which enhanced the expression of ABCA1 and increased cholesterol efflux rate. However, this effect was inhibited by PKAI in the RAW 264.7 cell line but not in the THP-1 cell line. CONCLUSIONS IMD can ameliorate the development of AS in ApoE-/- mice and regulate cholesterol balance in the RAW264.7 cell line through the cAMP-PKA pathway.

Citing Articles

Intermedin Inhibits the Ox-LDL-Induced Inflammation in RAW264.7 Cells by Affecting Fatty Acid-Binding Protein 4 Through the PKA Pathway.

Liu K, Shi R, Wang S, Liu Q, Zhang H, Chen X Front Pharmacol. 2021; 12:724777.

PMID: 34925001 PMC: 8671820. DOI: 10.3389/fphar.2021.724777.


Regulation of ATP binding cassette transporter A1 (ABCA1) expression: cholesterol-dependent and - independent signaling pathways with relevance to inflammatory lung disease.

He P, Gelissen I, Ammit A Respir Res. 2020; 21(1):250.

PMID: 32977800 PMC: 7519545. DOI: 10.1186/s12931-020-01515-9.

References
1.
Le Goff W, Zheng P, Brubaker G, Smith J . Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements. Arterioscler Thromb Vasc Biol. 2005; 26(3):527-33. DOI: 10.1161/01.ATV.0000201042.00725.84. View

2.
Oram J, Lawn R, Garvin M, Wade D . ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem. 2000; 275(44):34508-11. DOI: 10.1074/jbc.M006738200. View

3.
Aiello R, Brees D, Francone O . ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler Thromb Vasc Biol. 2003; 23(6):972-80. DOI: 10.1161/01.ATV.0000054661.21499.FB. View

4.
Bertolini S, Pisciotta L, Seri M, Cusano R, Cantafora A, Calabresi L . A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease. Atherosclerosis. 2001; 154(3):599-605. DOI: 10.1016/s0021-9150(00)00587-6. View

5.
Chang C, Roh J, Hsu S . Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates. Peptides. 2004; 25(10):1633-42. DOI: 10.1016/j.peptides.2004.05.021. View